"0950-222X" . "AlphaCor artificial cornea: clinical outcome"@en . "Eye" . "9"^^ . . . "Jir\u00E1skov\u00E1, Na\u010Fa" . "The long-term results of AlphaCor implantations, and evaluation of the main complications and risk factors were descrited. The survival rate of the device at 1, 2, and 3 years was 87%, 58%, and 42%, respectively. The most significant complications were stromal melt (nine cases), optic deposition (three eyes), and retroprosthetic membrane formation (three eyes). The most common device-unrelated complication was trauma (three patients). All complications were managed without loss of the eye. AlphaCor provides a treatment option for patients with corneal blindness in which a donor tissue graft would not succeed."@en . "9" . . "25" . "4"^^ . "185253" . "AlphaCor artificial cornea: clinical outcome" . "4"^^ . . . . "AlphaCor artificial cornea: clinical outcome"@en . . . "complications; outcomes; keratoprosthesis; AlphaCor"@en . . . "GB - Spojen\u00E9 kr\u00E1lovstv\u00ED Velk\u00E9 Brit\u00E1nie a Severn\u00EDho Irska" . "AlphaCor artificial cornea: clinical outcome" . . "RIV/00179906:_____/11:10104190" . "Burova, Mariya" . . "Kalfe\u0159tov\u00E1, Marie" . . "10.1038/eye.2011.122" . "Rozs\u00EDval, Pavel" . "http://www.nature.com/eye/journal/v25/n9/full/eye2011122a.html" . "RIV/00179906:_____/11:10104190!RIV12-MZ0-00179906" . "000294760300006" . . . "The long-term results of AlphaCor implantations, and evaluation of the main complications and risk factors were descrited. The survival rate of the device at 1, 2, and 3 years was 87%, 58%, and 42%, respectively. The most significant complications were stromal melt (nine cases), optic deposition (three eyes), and retroprosthetic membrane formation (three eyes). The most common device-unrelated complication was trauma (three patients). All complications were managed without loss of the eye. AlphaCor provides a treatment option for patients with corneal blindness in which a donor tissue graft would not succeed." . . . "[9F1C7EF2BFCC]" . . "I, Z(MZ0FNHK2005)" . . . .